BiotechTube

DGD

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Burn

Conditions

Burn

Trial Timeline

Dec 1, 2005 → Feb 1, 2010

NCT ID
NCT00324311

About DGD

DGD is a phase 3 stage product being developed by MediWound for Burn. The current trial status is completed. This product is registered under clinical trial identifier NCT00324311. Target conditions include Burn.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT00898521Phase 2Completed
NCT00324311Phase 3Completed

Competing Products

20 competing products in Burn

See all competitors
ProductCompanyStageHype Score
CefiderocolShionogiApproved
85
rabeprazole sodiumEisaiPhase 3
77
rabeprazole sodium + placeboEisaiPhase 3
77
Rabeprazole sodiumEisaiPre-clinical
23
famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with waterJohnson & JohnsonPhase 1
33
R-Pdf/Gbb 0.01% gelJohnson & JohnsonPhase 2
52
esomeprazole 40 mgAstraZenecaApproved
85
Esomeprazole magnesium (Nexium)AstraZenecaApproved
85
EsomeprazoleAstraZenecaPhase 3
77
EsomeprazoleAstraZenecaPhase 3
77
Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
85
Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
85
Ceftolozane/tazobactamMerckApproved
85
Famotidine FCT + Famotidine CTMerckPhase 1
33
LanzoprazoleNovartisPhase 3
77
Lansoprazole + Lansoprazole + placeboNovartisPhase 3
77
LansoprazoleNovartisPhase 3
77
Diclofenac sodium 1mg/gNovartisPhase 3
77
BVS857NovartisPhase 2
52
TegaserodNovartisPhase 3
77

Other Products from MediWound

NexoBrid + Gel VehiclePhase 3
69
NexoBridPhase 3
69
EscharEx (EX-03) + Placebo (Gel vehicle)Phase 3
69
EscharEx (5% EX-02 formulation) + Gel Vehicle + Non-surgical standard of care (NSSOC)Phase 2
44
EscharEx + Gel VehiclePhase 2
44